OncoMatch/Clinical Trials/NCT06798922
Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers
Is NCT06798922 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for oral cavity carcinoma.
Patients with oral cavity cancer treated by reconstructive surgery with a flap. Patients will be treated in the study for : * Experimental arm: Post-operative radiotherapy with flap sparing * Control arm: Standard post-operative radiotherapy without flap sparing (current practice) Radiotherapy by IMRT using photons or proton therapy (IMPT)
Check if I qualifyExtracted eligibility criteria
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Prior therapy
Must have received: reconstructive surgery with a flap
treated by reconstructive surgery with a flap
Cannot have received: radiotherapy of head and neck area
History of radiotherapy of head and neck area
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify